Home » Stocks » Conformis

Conformis, Inc. (CFMS)

Stock Price: $0.741 USD -0.015 (-1.98%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 57.47M
Revenue (ttm) 73.14M
Net Income (ttm) -25.62M
Shares Out 77.56M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $0.741
Previous Close $0.756
Change ($) -0.015
Change (%) -1.98%
Day's Open 0.759
Day's Range 0.740 - 0.768
Day's Volume 211,383
52-Week Range 0.500 - 2.390

More Stats

Market Cap 57.47M
Enterprise Value 69.42M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 77.56M
Float 69.92M
EPS (basic) -0.38
EPS (diluted) -0.39
FCF / Share -0.17
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 577,497
Short Ratio 1.16
Short % of Float 0.83%
Beta 1.80
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.79
PB Ratio 6.81
Revenue 73.14M
Operating Income -23.02M
Net Income -25.62M
Free Cash Flow -11.38M
Net Cash -11.96M
Net Cash / Share -0.15
Gross Margin 50.23%
Operating Margin -31.47%
Profit Margin -35.00%
FCF Margin -15.56%
ROA -21.43%
ROE -143.36%
ROIC -44.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$2.33*
(214.44% upside)
Low
2.00
Current: $0.741
High
3.00
Target: 2.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue77.4389.7978.1279.9066.8948.1934.60
Revenue Growth-13.77%14.94%-2.23%19.45%38.81%39.28%-
Gross Profit36.7448.4928.8126.7121.7915.817.31
Operating Income-25.13-38.69-55.85-56.14-55.96-45.43-47.31
Net Income-28.48-43.37-53.58-57.59-57.25-45.72-47.89
Shares Outstanding64.1258.8943.3441.5221.994.244.00
Earnings Per Share-0.44-0.74-1.24-1.39-2.60-10.78-11.98
Operating Cash Flow-2.84-25.18-37.86-49.13-54.45-43.54-46.83
Capital Expenditures-2.93-4.06-5.23-7.16-4.64-2.61-4.11
Free Cash Flow-5.76-29.24-43.09-56.29-59.09-46.15-50.94
Cash & Equivalents26.8624.0945.6965.8011842.3459.77
Total Debt26.1614.7929.67-0.4810.623.11
Net Cash / Debt0.699.3016.0265.8011731.7256.66
Assets72.4062.9893.8011315971.2883.89
Liabilities56.0526.7847.2918.7618.1621.4514.93
Book Value16.3536.2046.5194.0614149.8368.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Conformis, Inc.
Country United States
Employees 262
CEO Mark A. Augusti

Stock Information

Ticker Symbol CFMS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: CFMS
IPO Date July 1, 2015

Description

Conformis, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.